Khan et al classified patients requiring renal replacement therapy into risk groups. The authors are from Ninewells Hospital Dundee, University of Aberdeen, Univrsity of Nantes, Academic Hospital Nijmegen, Aristotelian University of Thessaloniki, and the University of Heidelberg.